 |
Conference papers
New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
Résumé : n.a
https://www.hal.inserm.fr/inserm-00668439
Contributor : Ed. Bmc <>
Submitted on : Thursday, February 9, 2012 - 5:13:00 PM
Last modification on : Friday, February 17, 2012 - 3:13:19 PM
Long-term archiving on: : Thursday, May 10, 2012 - 2:58:13 AM
Contributor : Ed. Bmc <>
Submitted on : Thursday, February 9, 2012 - 5:13:00 PM
Last modification on : Friday, February 17, 2012 - 3:13:19 PM
Long-term archiving on: : Thursday, May 10, 2012 - 2:58:13 AM